Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Clinical Trial

Published on 17 Aug 2023

Application of a warfarin dosing calculator to guide individualized dosing versus empirical adjustment after fixed dosing: a pilot study

in Drugs Outcomes Research and Policies

Xiaofang Cai
Jiana Chen
Maohua Chen
Xiaotong Xia
Guanhua Fang
Jinhua Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1235331

6,029 views
3 citations

Original Research

Published on 16 Aug 2023

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

in Drugs Outcomes Research and Policies

Rosanne Janssens
Liese Barbier
Mireille Muller
Irina Cleemput
Isabelle Stoeckert
Chiara Whichello
Bennett Levitan
Tarek A. Hammad
Charis Girvalaki
Juan-Jose Ventura

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192770

5,736 views
10 citations

Original Research

Published on 14 Aug 2023

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease

in Drugs Outcomes Research and Policies

Shuyan Li
Yan Ma
Hongling Sun
Zijun Ni
Shurong Hu
Yan Chen
Meijuan Lan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185026

1,964 views
5 citations

Original Research

Published on 11 Aug 2023

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension

in Drugs Outcomes Research and Policies

Wenxing Dong
Zhe Zhang
Mingming Chu
Peng Gu
Min Hu
Lulu Liu
Jingbin Huang
Rong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122866

4,260 views
4 citations

Original Research

Published on 10 Aug 2023

Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease

in Drugs Outcomes Research and Policies

Martin Wawruch
Miriam Petrova
Tomas Tesar
Jan Murin
Patricia Schnorrerova
Martina Paduchova
Denisa Celovska
Beata Havelkova
Michal Trnka
Sofa D. Alfian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199669

2,130 views
2 citations

Original Research

Published on 09 Aug 2023

Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China

in Drugs Outcomes Research and Policies

Zhen Feng
Wai Kei Tong
Xinyue Zhang
Zhijia Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226778

8,035 views
4 citations

Systematic Review

Published on 08 Aug 2023

Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reporting

in Drugs Outcomes Research and Policies

Jai Vithlani
Claire Hawksworth
Jamie Elvidge
Lynda Ayiku
Dalia Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1220950

10,199 views
15 citations

Systematic Review

Published on 08 Aug 2023

Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Qige Wei
Hui Wang
Jianglin Zhao
Zhongping Luo
Chufeng Wang
Chunmei Zhu
Na Su
Shengzhao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237234

7,167 views
14 citations

Original Research

Published on 04 Aug 2023

Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Xikui Lu
Lu Zhang
Hangxing Huang
Xiangping Wu
Zhenting Wang
Ling Huang
Jingyang Li
Huimin Yu
Hongyan Zhang
Jian Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1073939

2,481 views
1 citation

Original Research

Published on 04 Aug 2023

Dapagliflozin versus empagliflozin in patients with chronic kidney disease

in Drugs Outcomes Research and Policies

Hilmi Alnsasra
Gal Tsaban
Adam Solomon
Fouad Khalil
Enis Aboalhasan
Abed N. Azab
Joseph Azuri
Ariel Hammerman
Ronen Arbel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227199

60,761 views
7 citations

Original Research

Published on 03 Aug 2023

An analysis of pharmacy workforce capacity in Saudi Arabia

in Drugs Outcomes Research and Policies

Dalia Almaghaslah

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219528

4,039 views
6 citations

Original Research

Published on 03 Aug 2023

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China

in Drugs Outcomes Research and Policies

Rui Luo
He Lu
Hengfen Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1238028

3,017 views
1 citation

Policy and Practice Reviews

Published on 02 Aug 2023

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

in Drugs Outcomes Research and Policies

Kamila Urbańczyk
Sonja Guntschnig
Vasilis Antoniadis
Slaven Falamic
Tijana Kovacevic
Marta Kurczewska-Michalak
Branislava Miljković
Anna Olearova
Inese Sviestina
Attila Szucs

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244151

20,698 views
30 citations

Mini Review

Published on 31 Jul 2023

Cell-based medicinal products approved in the European Union: current evidence and perspectives

in Drugs Outcomes Research and Policies

Stefania Bellino
Anna La Salvia
Maria Francesca Cometa
Rosanna Botta

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200808

14,942 views
14 citations

Original Research

Published on 27 Jul 2023

Cost-effectiveness of maintenance niraparib with an individualized starting dosage in patients with platinum-sensitive recurrent ovarian cancer in China

in Drugs Outcomes Research and Policies

Yin Shi
Di Xiao
Shuishi Li
Shao Liu
Yu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1198585

2,436 views
1 citation

Original Research

Published on 26 Jul 2023

The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer

in Drugs Outcomes Research and Policies

Tingting Lu
Yufan Huang
Zhongjie Cai
Wangchun Lin
Xiaoxiao Chen
Ruijia Chen
Yingying Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1171302

2,449 views
2 citations